|
|
Previous Article | Table of Contents | Next Article 
Tyrosine phosphorylation of the erythropoietin receptor: role for
differentiation and mitogenic signal transduction
S Gobert, F Porteu, S Pallu, O Muller, M Sabbah, I Dusanter-Fourt, G Courtois, C Lacombe, S Gisselbrecht and P Mayeux
Institut Cochin de Genetique Moleculaire (ICGM), Universite Rene Descartes,
Paris, France.
The erythropoietin (Epo) receptor belongs to the cytokine receptor
superfamily. Although the cytokine receptors do not possess a tyrosine
kinase consensus sequence in the intracellular domain, rapid stimulation of
a tyrosine kinase activity occurs after activation by the ligand. We and
others have shown that Epo induces the tyrosine phosphorylation of its
cognate receptor as well as phosphorylation of other proteins. In this
report, we examined the role of the receptor tyrosine residues in signal
transduction. Eight tyrosine residues are located within the intracellular
domain of the murine Epo receptor. A single tyrosine residue is present in
the region previously shown to be sufficient for proliferative signal
transduction. This tyrosine (Tyr 343) was mutated to phenylalanine.
Moreover, mutant receptors were also generated with either a tyrosine
residue or a phenylalanine residue at position 343 and with a COOH terminal
truncation that removed the 7 other tyrosine residues. Expression vectors
carrying these mutated receptors were transfected into the
interleukin-3-dependent murine cell line Ba/F3. Epo-induced growth was
sustained efficiently by all these receptors, although receptors without
any tyrosine residues conferred a significantly reduced mitogenic activity.
Moreover, all receptors were able to mediate Epo-dependant accumulation of
beta-globin mRNA. The mutated receptors all induced the tyrosine
phosphorylation of several cellular proteins after Epo stimulation.
However, the truncated receptors induced the phosphorylation of a reduced
number of proteins, suggesting that phosphorylated tyrosines of the
receptor could have a role in the recruitment either of a tyrosine kinase
or of tyrosine kinase substrate proteins. The receptors were all able to
mediate Epo- induced activation of phosphatidylinositol 3-kinase, although
truncated receptors no longer bound phosphatidylinositol 3-kinase.
Volume 86,
Issue 2,
pp. 598-606,
07/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Buchse, H. Prietzsch, T. Sasse, S. Korbel, G. Stigge, S. Bogdanow, J. Brock, and T. Bittorf
Profiling of Early Gene Expression Induced by Erythropoietin Receptor Structural Variants
J. Biol. Chem.,
March 24, 2006;
281(12):
7697 - 7707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bouscary, F. Pene, Y.-E. Claessens, O. Muller, S. Chretien, M. Fontenay-Roupie, S. Gisselbrecht, P. Mayeux, and C. Lacombe
Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation
Blood,
May 1, 2003;
101(9):
3436 - 3443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Miller, D. W. Heilman, and D. M. Wojchowski
Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms
Blood,
February 1, 2002;
99(3):
898 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nishigaki, C. Hanson, T. Ohashi, D. Thompson, K. Muszynski, and S. Ruscetti
Erythroid Cells Rendered Erythropoietin Independent by Infection with Friend Spleen Focus-Forming Virus Show Constitutive Activation of Phosphatidylinositol 3-Kinase and Akt Kinase: Involvement of Insulin Receptor Substrate-Related Adapter Proteins
J. Virol.,
April 1, 2000;
74(7):
3037 - 3045.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. P. Miller, Z. Y. Liu, C. T. Noguchi, and D. M. Wojchowski
A Minimal Cytoplasmic Subdomain of the Erythropoietin Receptor Mediates Erythroid and Megakaryocytic Cell Development
Blood,
November 15, 1999;
94(10):
3381 - 3387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Haseyama, K.-i. Sawada, A. Oda, K. Koizumi, H. Takano, T. Tarumi, M. Nishio, M. Handa, Y. Ikeda, and T. Koike
Phosphatidylinositol 3-Kinase Is Involved in the Protection of Primary Cultured Human Erythroid Precursor Cells From Apoptosis
Blood,
September 1, 1999;
94(5):
1568 - 1577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lecoq-Lafon, F. Verdier, S. Fichelson, S. Chretien, S. Gisselbrecht, C. Lacombe, and P. Mayeux
Erythropoietin Induces the Tyrosine Phosphorylation of GAB1 and Its Association With SHC, SHP2, SHIP, and Phosphatidylinositol 3-Kinase
Blood,
April 15, 1999;
93(8):
2578 - 2585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Milocco, J. A. Haslam, J. Rosen, and H. M. Seidel
Design of Conditionally Active STATs: Insights into STAT Activation and Gene Regulatory Function
Mol. Cell. Biol.,
April 1, 1999;
19(4):
2913 - 2920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bouillie, M. Barel, and R. Frade
Signaling Through the EBV/C3d Receptor (CR2, CD21) in Human B Lymphocytes: Activation of Phosphatidylinositol 3-Kinase via a CD19-Independent Pathway
J. Immunol.,
January 1, 1999;
162(1):
136 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Duprez, U. Blank, S. Chretien, S. Gisselbrecht, and P. Mayeux
Physical and Functional Interaction between p72syk and Erythropoietin Receptor
J. Biol. Chem.,
December 18, 1998;
273(51):
33985 - 33990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Verdier, S. Chretien, O. Muller, P. Varlet, A. Yoshimura, S. Gisselbrecht, C. Lacombe, and P. Mayeux
Proteasomes Regulate Erythropoietin Receptor and Signal Transducer and Activator of Transcription 5 (STAT5) Activation. POSSIBLE INVOLVEMENT OF THE UBIQUITINATED CIS PROTEIN
J. Biol. Chem.,
October 23, 1998;
273(43):
28185 - 28190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gesbert, C. Guenzi, and J. Bertoglio
A New Tyrosine-phosphorylated 97-kDa Adaptor Protein Mediates Interleukin-2-induced Association of SHP-2 with p85-Phosphatidylinositol 3-Kinase in Human T Lymphocytes
J. Biol. Chem.,
July 17, 1998;
273(29):
18273 - 18281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Longmore, Y. You, J. Molden, K. D. Liu, A. Mikami, S. Y. Lai, P. Pharr, and M. A. Goldsmith
Redundant and Selective Roles for Erythropoietin Receptor Tyrosines in Erythropoiesis In Vivo
Blood,
February 1, 1998;
91(3):
870 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bergelson, U. Klingmuller, M. Socolovsky, J. G. Hsiao, and H. F. Lodish
Tyrosine Residues within the Intracellular Domain of the Erythropoietin Receptor Mediate Activation of AP-1 Transcription Factors
J. Biol. Chem.,
January 23, 1998;
273(4):
2396 - 2401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Verdier, S. Chretien, C. Billat, S. Gisselbrecht, C. Lacombe, and P. Mayeux
Erythropoietin Induces the Tyrosine Phosphorylation of Insulin Receptor Substrate-2. AN ALTERNATE PATHWAY FOR ERYTHROPOIETIN-INDUCED PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION
J. Biol. Chem.,
October 17, 1997;
272(42):
26173 - 26178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ishiguro and A. C. Sartorelli
Clonal Variability in beta -Globin mRNA Content in an Interleukin-3-Dependent Bone Marrow Cell Line Transfected With the Erythropoietin Receptor Before and After Stimulation With Erythropoietin
Blood,
September 15, 1997;
90(6):
2273 - 2281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Komatsu, K. Kirito, R. Shimizu, M. Kunitama, M. Yamada, M. Uchida, M. Takatoku, M. Eguchi, and Y. Miura
In Vitro Development of Erythroid and Megakaryocytic Cells From a UT-7 Subline, UT-7/GM
Blood,
June 1, 1997;
89(11):
4021 - 4033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shigematsu, H. Iwasaki, T. Otsuka, Y. Ohno, F. Arima, and Y. Niho
Role of the vav Proto-oncogene Product (Vav) in Erythropoietin-mediated Cell Proliferation and Phosphatidylinositol 3-Kinase Activity
J. Biol. Chem.,
May 30, 1997;
272(22):
14334 - 14340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tarr, S. S. Watowich, and G. D. Longmore
Cell Surface Organization of the Erythropoietin Receptor Complex Differs Depending on its Mode of Activation
J. Biol. Chem.,
April 4, 1997;
272(14):
9099 - 9107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Hoefsloot, M. P. van Amelsvoort, L. C.A.M. Broeders, D. C. van der Plas, K. van Lom, H. Hoogerbrugge, I. P. Touw, and B. Lowenberg
Erythropoietin-Induced Activation of STAT5 Is Impaired in the Myelodysplastic Syndrome
Blood,
March 1, 1997;
89(5):
1690 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Feger, A. Dubart, C. Lacout, I. Dusanter-Fourt, P. Mayeux, W. Vainchenker, and D. Dumenil
Ectopic Expression of the Erythropoietin Receptor in a Murine Interleukin-6-Dependent Plasmacytoma Cell Line (TEPC-2027) Confers Proliferative Responsiveness to Erythropoietin
Blood,
January 15, 1997;
89(2):
435 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Barber, C. N. Corless, K. Xia, T. M. Roberts, and A. D. D'Andrea
Erythropoietin Activates Raf1 by an Shc-Independent Pathway in CTLL-EPO-R Cells
Blood,
January 1, 1997;
89(1):
55 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Pircher, J. N. Geiger, D. Zhang, C. P. Miller, P. Gaines, and D. M. Wojchowski
Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-Kit
J. Biol. Chem.,
March 16, 2001;
276(12):
8995 - 9002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Verdier, P. Walrafen, N. Hubert, S. Chretien, S. Gisselbrecht, C. Lacombe, and P. Mayeux
Proteasomes Regulate the Duration of Erythropoietin Receptor Activation by Controlling Down-regulation of Cell Surface Receptors
J. Biol. Chem.,
June 9, 2000;
275(24):
18375 - 18381.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|